✦ LIBER ✦

CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer

✍ Scribed by Ahmed, M. A.H. (author);Al-Attar, A. (author);Kim, J. (author);Watson, N. F.S. (author);Scholefield, J. H. (author);Durrant, L. G. (author);Ilyas, M. (author)

Book ID: 121349479
Publisher: BMJ Publishing Group
Year: 2009
Tongue: English
Weight: 488 KB
Volume: 62
Category: Article
ISSN: 0021-9746
DOI: 10.1136/jcp.2009.069310

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD24 shows early upregulation and nuclea

CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer

✍ Ahmed, M. A.H. (author);Al-Attar, A. (author);Kim, J. (author);Watson, N. F.S. ( 📂 Article 📅 2009 🏛 BMJ Publishing Group 🌐 English ⚖ 488 KB

REG1A expression is a prognostic marker

REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis

✍ Christian Astrosini; Claudia Roeefzaad; Yi-Yang Dai; Brian K. Dieckgraefe; Thoma 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 269 KB

## Abstract By expression profiling of early staged colon carcinomas, we found __regenerating islet‐derived 1 alpha__ (__REG1A__) to be upregulated in patients with an unfavorable clinical outcome. For validation, __REG1A__ expression was quantified in another colorectal cancer (CRC) patient cohort

DSC3 expression is regulated by p53, and

DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer

✍ Cui, T; Chen, Y; Yang, L; Knösel, T; Zöller, K; Huber, O; Petersen, I 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 488 KB

CD133 expression is not an independent p

CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy

✍ Khalilullah Mia-Jan, So Young Jung, Ik-Yong Kim, Sung Soo Oh, EunHee Choi… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 562 KB

p27Kip1 is a predictive factor for tamox

p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients

✍ Maria Stendahl; Sofie Nilsson; Caroline Wigerup; Karin Jirström; Per Ebbe Jönsso 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 489 KB

## Abstract The cell‐cycle regulating protein p27^Kip1^ (p27) has dual roles by acting as both a cdk inhibitor and as an assembly factor for different cdk complexes. Loss of p27 has been linked to malignant features in tumours; however, the exact role of p27 deregulation in breast cancer regarding

Hypoxia inducible factor-1α is a prognos

Hypoxia inducible factor-1α is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response

✍ Åsa Kronblad; Karin Jirström; Lisa Rydén; Bo Nordenskjöld; Göran Landberg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 765 KB

## Abstract Hypoxia is common in many solid tumours, including breast cancer. Hypoxia triggers the expression of hypoxia inducible factor‐1α (HIF‐1α), and HIF‐1α has been associated with an impaired prognosis in breast cancer and down‐regulation of the oestrogen receptor (ER), potentially affecting